Benzinga | May 12, 2021 04:27PM EDT

Aspira Women's Health Initiates Prospective Clinical Study For Benign Risk Monitoring And High Risk Early Ovarian Cancer Detection With Northwell Health

Aspira Women's Health, Inc. (NASDAQ:AWH), a bioanalytical-based women's health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest private Healthcare Provider in New York State, today announced the start of a prospective Clinical Study for Ovarian Cancer Risk Detection. Northwell Health treats over 2 million patients annually and employs over 16,000 credentialled physicians.